Showing results (241-250 of 296) with videos related to
Sort By:
Pageof 30
Gastroenterology|June 16, 2010
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reductionAlexander J Thompson, Jacques Fellay, Keyur Patel, et al.Alimentary Pharmacology & Therapeutics|January 30, 2018
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapyD M Evon, J Amador, P Stewart, et al.Journal of Hepatology|June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis CStefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV InfectionMayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.Journal of Hepatology|September 15, 2014
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGETStuart C Gordon, Andrew J Muir, Joseph K Lim, et al.Journal of Viral Hepatitis|January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral TherapyAmit G Singal, K Rajender Reddy, Massimo Colombo, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2021
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH StudyMary J Thomson, Marina Serper, Vandana Khungar, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 11, 2019
HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype DefinitionWillem P Brouwer, Qian Zhao, Bettina E Hansen, et al.The New England Journal of Medicine|July 1, 2005
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis BGeorge K K Lau, Teerha Piratvisuth, Kang Xian Luo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.Pageof 30